F772 in Maryland. Pick another state for the same tag.
Against expectation — 2024
Maryland cites F772 more often than its own record predicts
Versus expected share6.81×
6.81 times the share F772 takes of citations nationally.
Share of Maryland citations0.11%
Of every deficiency written in Maryland in 2024, this is the portion that was F772.
Maryland0.11%
National0.02%
Share of all citations that were F772.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Maryland surveyors wrote
F772 findings written in Maryland, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedOctober 16, 2024
Based on record review and interviews, it was determined that the facility failed to have a system in place that assured accurate entry was completed to enable the ability for laboratory specimens to be processed by an outside company. This was found evident in 5 out of 8 laboratory samples reviewed for Resident #28.
The findings include:
On 10/3/24 at 2:30 PM, the surveyor reviewed Resident #28's laboratory results. On 9/3/24 Resident #28 was ordered to have blood samples for a Comprehensive Metabolic Panel (CMP), Lipid Panel, Complete Blood Count (CBC) with differential, and a stool sample for Clostridioides difficile (C-diff). …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction